Overview of redox regulation by Keap1–Nrf2 system in toxicology and cancer

Itoh, 1997, An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements, Biochem Biophys Res Commun, 236, 313, 10.1006/bbrc.1997.6943 Itoh, 1999, Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain, Genes Dev, 13, 76, 10.1101/gad.13.1.76 Kobayashi, 2004, Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2, Mol Cell Biol, 24, 7130, 10.1128/MCB.24.16.7130-7139.2004 Katsuoka, 2005, Genetic evidence that small maf proteins are essential for the activation of antioxidant response element-dependent genes, Mol Cell Biol, 25, 8044, 10.1128/MCB.25.18.8044-8051.2005 Motohashi, 2004, Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1–Nrf2 regulatory pathway, Proc Natl Acad Sci U S A, 101, 6379, 10.1073/pnas.0305902101 McMahon, 2003, Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression, J Biol Chem, 278, 21592, 10.1074/jbc.M300931200 Rada, 2011, SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner, Mol Cell Biol, 31, 1121, 10.1128/MCB.01204-10 Chowdhry, 2013, Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity, Oncogene, 32, 3765, 10.1038/onc.2012.388 Salazar, 2006, Glycogen synthase kinase-3beta inhibits the xenobiotic and antioxidant cell response by direct phosphorylation and nuclear exclusion of the transcription factor Nrf2, J Biol Chem, 281, 14841, 10.1074/jbc.M513737200 Rushmore, 1991, The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity, J Biol Chem, 266, 11632, 10.1016/S0021-9258(18)99004-6 Friling, 1990, Xenobiotic-inducible expression of murine glutathione S-transferase Ya subunit gene is controlled by an electrophile-responsive element, Proc Natl Acad Sci U S A, 87, 6258, 10.1073/pnas.87.16.6258 Otsuki, 2016, Unique cistrome defined as CsMBE is strictly required for Nrf2–sMaf heterodimer function in cytoprotection, Free Radic Biol Med, 91, 45, 10.1016/j.freeradbiomed.2015.12.005 Malhotra, 2010, Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis, Nucleic Acids Res, 38, 5718, 10.1093/nar/gkq212 Chorley, 2012, Identification of novel NRF2-regulated genes by ChIP-Seq: influence on retinoid X receptor alpha, Nucleic Acids Res, 40, 7416, 10.1093/nar/gks409 Hirotsu, 2012, Nrf2–MafG heterodimers contribute globally to antioxidant and metabolic networks, Nucleic Acids Res, 40, 10228, 10.1093/nar/gks827 Suzuki, 2013, Toward clinical application of the Keap1–Nrf2 pathway, Trends Pharmacol Sci, 34, 340, 10.1016/j.tips.2013.04.005 Mitsuishi, 2012, Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming, Cancer Cell, 22, 66, 10.1016/j.ccr.2012.05.016 Taguchi, 2016, Generation of a new model rat: Nrf2 knockout rats are sensitive to aflatoxin B1 toxicity, Toxicol Sci, 152, 40, 10.1093/toxsci/kfw065 Taguchi, 2010, Genetic analysis of cytoprotective functions supported by graded expression of Keap1, Mol Cell Biol, 30, 3016, 10.1128/MCB.01591-09 Okawa, 2006, Hepatocyte-specific deletion of the Keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity, Biochem Biophys Res Commun, 339, 79, 10.1016/j.bbrc.2005.10.185 Wakabayashi, 2003, Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation, Nat Genet, 35, 238, 10.1038/ng1248 Dinkova-Kostova, 2002, Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants, Proc Natl Acad Sci U S A, 99, 11908, 10.1073/pnas.172398899 Takaya, 2012, Validation of the multiple sensor mechanism of the Keap1–Nrf2 system, Free Radic Biol Med, 53, 817, 10.1016/j.freeradbiomed.2012.06.023 Saito, 2015, Characterizations of three major cysteine sensors of Keap1 in stress response, Mol Cell Biol, 36, 271, 10.1128/MCB.00868-15 Uruno, 2013, The Keap1–Nrf2 system prevents onset of diabetes mellitus, Mol Cell Biol, 33, 2996, 10.1128/MCB.00225-13 Yagishita, 2014, Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice, Diabetes, 63, 605, 10.2337/db13-0909 Keleku-Lukwete, 2015, Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation, Proc Natl Acad Sci U S A, 112, 12169, 10.1073/pnas.1509158112 Katoh, 2001, Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription, Genes Cells, 6, 857, 10.1046/j.1365-2443.2001.00469.x Fukutomi, 2014, Kinetic, thermodynamic, and structural characterizations of the association between Nrf2–DLGex degron and Keap1, Mol Cell Biol, 34, 832, 10.1128/MCB.01191-13 Tong, 2006, Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model, Mol Cell Biol, 26, 2887, 10.1128/MCB.26.8.2887-2900.2006 Tong, 2007, Different electrostatic potentials define ETGE and DLG motifs as hinge and latch in oxidative stress response, Mol Cell Biol, 27, 7511, 10.1128/MCB.00753-07 Ogura, 2010, Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains, Proc Natl Acad Sci U S A, 107, 2842, 10.1073/pnas.0914036107 Padmanabhan, 2005, Purification, crystallization and preliminary X-ray diffraction analysis of the Kelch-like motif region of mouse Keap1, Acta Crystallogr Sect F Struct Biol Cryst Commun, 61, 153, 10.1107/S1744309104032506 Padmanabhan, 2006, Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer, Mol Cell, 21, 689, 10.1016/j.molcel.2006.01.013 Taguchi, 2014, Nrf2 enhances cholangiocyte expansion in Pten-deficient livers, Mol Cell Biol, 34, 900, 10.1128/MCB.01384-13 Shibata, 2008, Cancer related mutations in NRF2 impair its recognition by Keap1–Cul3 E3 ligase and promote malignancy, Proc Natl Acad Sci U S A, 105, 13568, 10.1073/pnas.0806268105 Solis, 2010, Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features, Clin Cancer Res, 16, 3743, 10.1158/1078-0432.CCR-09-3352 Inoue, 2012, Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma, Cancer Sci, 103, 760, 10.1111/j.1349-7006.2012.02216.x Shibata, 2008, Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer, Gastroenterology, 135, 1358, 10.1053/j.gastro.2008.06.082 Shibata, 2011, NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer, Neoplasia, 13, 864, 10.1593/neo.11750 Ichimura, 2013, Phosphorylation of p62 activates the Keap1–Nrf2 pathway during selective autophagy, Mol Cell, 51, 618, 10.1016/j.molcel.2013.08.003 Komatsu, 2010, The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1, Nat Cell Biol, 12, 213, 10.1038/ncb2021 Lau, 2010, A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62, Mol Cell Biol, 30, 3275, 10.1128/MCB.00248-10 Adam, 2011, Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling, Cancer Cell, 20, 524, 10.1016/j.ccr.2011.09.006 Ooi, 2011, An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma, Cancer Cell, 20, 511, 10.1016/j.ccr.2011.08.024 DeNicola, 2011, Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis, Nature, 475, 106, 10.1038/nature10189 Wang, 2008, Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues, Biochem Biophys Res Commun, 373, 151, 10.1016/j.bbrc.2008.06.004 Ren, 2011, Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism, Proc Natl Acad Sci U S A, 108, 1433, 10.1073/pnas.1014275108 Vartanian, 2016, Application of mass spectrometry profiling to establish brusatol as an inhibitor of global protein synthesis, Mol Cell Proteomics, 15, 1220, 10.1074/mcp.M115.055509 Saito, 2016, p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming, Nat Commun, 7, 12030, 10.1038/ncomms12030 Gabrilovich, 2009, Myeloid-derived suppressor cells as regulators of the immune system, Nat Rev Immunol, 9, 162, 10.1038/nri2506 Satoh, 2010, Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung, Carcinogenesis, 31, 1833, 10.1093/carcin/bgq105 Hiramoto, 2014, Myeloid lineage-specific deletion of antioxidant system enhances tumor metastasis, Cancer Prev Res (Phila), 7, 835, 10.1158/1940-6207.CAPR-14-0094 Kobayashi, 2016, Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription, Nat Commun, 7, 11624, 10.1038/ncomms11624 Satoh, 2016, NRF2 intensifies host defense systems to prevent lung carcinogenesis, but after tumor initiation accelerates malignant cell growth, Cancer Res, 76, 3088, 10.1158/0008-5472.CAN-15-1584